Arcus Biosciences (RCUS) Return on Sales (2017 - 2026)

Arcus Biosciences' Return on Sales history runs 10 years deep, the most recent figure standing at 0.08% for Q1 2026.

• In Q1 2026, Return on Sales fell 4.0% year-over-year to 0.08%; the TTM figure through Mar 2026 stood at 0.02% (up 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Sales was 0.08% for Q1 2026 at Arcus Biosciences, down from 0.03% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2024 to a low of 0.08% in Q1 2026.
• Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.03% in 2023.
• The sharpest annual moves came in 2022 and 2023: Return on Sales rose 6 bps in 2022, then slipped 4 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then plunged by 194 bps to 0.06% in 2023, then jumped by 38 bps to 0.04% in 2024, then advanced by 11 bps to 0.03% in 2025, then plunged by 134 bps to 0.08% in 2026.
• The last three Return on Sales figures came in at 0.08% (Q1 2026), 0.03% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.